ALLERVI 120 mg, film-coated tablet 7 tablets
Active ingredients: Fexofenadine hydrochloride
Commercialized according to BDPM
Film-coated tablet7 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ALLERVI 120 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène PVDC aluminium de 7 comprimé(s)
- Marketing authorisation holder
- OPELLA HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Mar 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68712285CIP72748180CIP133400927481802Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE FEXOFÉNADINEcomprimé | 120,000 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.